Sylvie Turenne

405 total citations
8 papers, 329 citations indexed

About

Sylvie Turenne is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Biological Psychiatry. According to data from OpenAlex, Sylvie Turenne has authored 8 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 4 papers in Molecular Biology and 2 papers in Biological Psychiatry. Recurrent topics in Sylvie Turenne's work include Neurotransmitter Receptor Influence on Behavior (6 papers), Tryptophan and brain disorders (2 papers) and Forensic Toxicology and Drug Analysis (2 papers). Sylvie Turenne is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (6 papers), Tryptophan and brain disorders (2 papers) and Forensic Toxicology and Drug Analysis (2 papers). Sylvie Turenne collaborates with scholars based in Canada, United States and United Kingdom. Sylvie Turenne's co-authors include Brian M. Ross, Stephen J. Kish, Anna Moszczyńska, Jerry J. Warsh, Mary V. Seeman, Shepard Siegel, Linda A. Parker, Kathryn S. Kalasinsky, Paul Fletcher and Margaret Lee and has published in prestigious journals such as Brain Research, European Journal of Pharmacology and Schizophrenia Research.

In The Last Decade

Sylvie Turenne

8 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Turenne Canada 8 145 128 58 54 43 8 329
Cindie Courtin France 12 183 1.3× 146 1.1× 73 1.3× 38 0.7× 66 1.5× 21 396
Marie Cahir United Kingdom 11 229 1.6× 163 1.3× 39 0.7× 70 1.3× 33 0.8× 12 377
Sujan C. Das United States 10 258 1.8× 159 1.2× 35 0.6× 58 1.1× 22 0.5× 13 365
Dawn N. Albertson United States 4 171 1.2× 150 1.2× 56 1.0× 20 0.4× 13 0.3× 9 321
Szilvia Vas Hungary 12 134 0.9× 94 0.7× 49 0.8× 69 1.3× 29 0.7× 29 490
Brandon S. Pruett United States 11 221 1.5× 113 0.9× 68 1.2× 29 0.5× 17 0.4× 19 405
Wouter J. Florijn Netherlands 11 303 2.1× 217 1.7× 31 0.5× 19 0.4× 57 1.3× 20 458
Bálint Scheich Hungary 9 161 1.1× 139 1.1× 107 1.8× 23 0.4× 35 0.8× 18 374
Christin Glorioso United States 6 110 0.8× 121 0.9× 65 1.1× 46 0.9× 18 0.4× 12 362
Katia Boutourlinsky France 7 218 1.5× 124 1.0× 35 0.6× 36 0.7× 15 0.3× 9 338

Countries citing papers authored by Sylvie Turenne

Since Specialization
Citations

This map shows the geographic impact of Sylvie Turenne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Turenne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Turenne more than expected).

Fields of papers citing papers by Sylvie Turenne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Turenne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Turenne. The network helps show where Sylvie Turenne may publish in the future.

Co-authorship network of co-authors of Sylvie Turenne

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Turenne. A scholar is included among the top collaborators of Sylvie Turenne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Turenne. Sylvie Turenne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ross, Brian M., Robert J. Brooks, Margaret Lee, et al.. (2002). Cyclooxygenase inhibitor modulation of dopamine-related behaviours. European Journal of Pharmacology. 450(2). 141–151. 29 indexed citations
2.
Ross, Brian M. & Sylvie Turenne. (2002). Chronic cocaine administration reduces phospholipase A2 activity in rat brain striatum. Prostaglandins Leukotrienes and Essential Fatty Acids. 66(5-6). 479–483. 9 indexed citations
3.
Ross, Brian M., Anna Moszczyńska, Frank J. Peretti, et al.. (2002). Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine. Drug and Alcohol Dependence. 67(1). 73–79. 32 indexed citations
4.
Turenne, Sylvie, Mary V. Seeman, & Brian M. Ross. (2001). An animal model of nicotinic-acid-induced vasodilation: effect of haloperidol, caffeine and nicotine upon nicotinic acid response. Schizophrenia Research. 50(3). 191–197. 34 indexed citations
5.
Ross, Brian M., Sylvie Turenne, Anna Moszczyńska, Jerry J. Warsh, & Stephen J. Kish. (1999). Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia. Brain Research. 821(2). 407–413. 100 indexed citations
7.
Moszczyńska, Anna, Sylvie Turenne, & Stephen J. Kish. (1998). Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine. Neuroscience Letters. 255(1). 49–52. 48 indexed citations
8.
Turenne, Sylvie, et al.. (1996). Individual differences in reactivity to the rewarding/aversive properties of drugs: Assessment by taste and place conditioning. Pharmacology Biochemistry and Behavior. 53(3). 511–516. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026